胶质瘤钙离子通道研究进展

国际肿瘤学杂志››2014,Vol. 41››Issue (8): 579-582.doi:10.3760/cma.j.issn.1673-422X.2014.08.007

刘洋,汪延明

250031济南军区总医院放疗科

收稿日期:2014-02-24修回日期:2014-03-25出版日期:2014-08-15发布日期:2014-08-14
通讯作者:汪延明，E-mail:ymwang64@163.com E-mail:ymwang64@163.com

Calcium channels in glioma

Liu Yang, Wamg Yanming

Department of Radiation Oncology, Ji′nan Military General Hospital, Ji′nan 250031, China

Received:2014-02-24Revised:2014-03-25Online:2014-08-15Published:2014-08-14
Contact:Wamg Yanming E-mail:ymwang64@163.com

摘要/Abstract

摘要：钙离子通道在神经胶质瘤中异常表达，并且在胶质瘤的发生、增殖、转移、肿瘤血管生成等方面起关键性作用。研究发现，不同类型钙通道表达升高或下降能够影响胶质瘤的生长发展及其细胞周期的再分布，提示其可能成为胶质瘤治疗的新靶点，为控制胶质瘤的进展提供新的思路。

刘洋,汪延明. 胶质瘤钙离子通道研究进展[J]. 国际肿瘤学杂志, 2014, 41(8): 579-582.

Liu Yang, Wamg Yanming. Calcium channels in glioma[J]. Journal of International Oncology, 2014, 41(8): 579-582.

［1］ Prevarskaya N, Skryma R, Shuba Y. Targeting Ca2+ transport in cancer: close reality or long perspective?［J］. Expert Opin Ther Targets, 2013, 17(3): 225-241. ［2］ Taylor JT, Zeng XB, Pottle JE, et al. Calcium signaling and Ttype calcium channels in cancer cell cycling［J］. World J Gastroenterol, 2008, 14(32): 4984-4991. ［3］ Lu F, Chen H, Zhou C, et al. Ttype Ca2+ channel expression in human esophageal carcinomas: a functional role in proliferation［J］. Cell Calcium, 2008, 43(1): 4958. ［4］ Ohkubo T, Yamazaki J. Ttype voltageactivated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF7 human breast cancer cells［J］. Int J Oncol, 2012, 41(1): 267-275. ［5］ Li W, Zhang SL, Wang N, et al. Blockade of Ttype Ca2+ channels inhibits human ovarian cancer cell proliferation［J］. Cancer Invest, 2011, 29(5): 339-346. ［6］ Zhang Y, Zhang J, Jiang D, et al. Inhibition of Ttype Ca2+ channels by endostatin attenuates human glioblastoma cell proliferation and migration［J］. Br J Pharmacol, 2012, 166(4): 1247-1260. ［7］ Valerie NC, Dziegielewska B, Hosing AS, et al. Inhibition of Ttype calcium channels disrupts Akt signaling and promotes apoptosis in glioblastoma cells［J］. Biochem Pharmacol, 2013, 85(7): 888-897. ［8］ Sheehan JP, Xu Z, Popp B, et al. Inhibition of glioblastoma and enhancement of survival via the use of mibefradil in conjunction with radiosurgery［J］. J Neurosurg, 2013, 118(4): 830-837. ［9］ Keir ST, Friedman HS, Reardon DA, et al. Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model［J］. J Neurooncol, 2013, 111(2): 97-102. ［10］ Santoni G, Farfariello V. TRP channels and cancer: new targets for diagnosis and chemotherapy［J］. Endocr Metab Immune Disord Drug Targets, 2011, 11(1): 54-67. ［11］ Prevarskaya N, Zhang L, Barritt G. TRP channels in cancer［J］. Biochim Biophys Acta, 2007, 1772(8): 937-946. ［12］ Gkika D, Prevarskaya N. Molecular mechanisms of TRP regulation in tumor growth and metastasis［J］. Biochim Biophys Acta, 2009, 1793(6): 953-958. ［13］ Santoni G, Farfariello V, Amantini C. TRPV channels in tumor growth and progression［J］. Adv Exp Med Biol, 2011, 704: 947-967. ［14］ Bomben VC, Sontheimer HW. Inhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas［J］. Cell Prolif, 2008, 41(1): 98-121. ［15］ Bomben VC, Sontheimer H. Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas［J］. Glia, 2010, 58(10): 1145-1156. ［16］ Malarkey EB, Ni Y, Parpura V. Ca2+ entry through TRPC1 channels contributes to intracellular Ca2+ dynamics and consequent glutamate release from rat astrocytes［J］. Glia, 2008, 56(8): 821-835. ［17］ Ding X, He Z, Zhou K, et al. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma［J］. J Natl Cancer Inst, 2010, 102(14): 1052-1068. ［18］ Chigurupati S, Venkataraman R, Barrera D, et al. Receptor channel TRPC6 is a key mediator of Notchdriven glioblastoma growth and invasiveness［J］. Cancer Res, 2010, 70(1): 418-427. ［19］ Amantini C, Mosca M, Nabissi M, et al. Capsaicininduced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation［J］. J Neurochem, 2007, 102(3): 977-990. ［20］ Stock K, Kumar J, Synowitz M, et al. Neural precursor cells induce cell death of highgrade astrocytomas through stimulation of TRPV1［J］. Nat Med, 2012, 18(8): 1232-1238. ［21］ Nabissi M, Morelli MB, Amantini C, et al. TRPV2 channel negatively controls glioma cell proliferation and resistance to Fasinduced apoptosis in ERKdependent manner［J］. Carcinogenesis, 2010, 31(5): 794-803. ［22］ Nabissi M, Morelli MB, Santoni M, et al. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents［J］. Carcinogenesis, 2013, 34(1): 48-57.

[1]	刘萍萍, 何学芳, 张翼, 杨旭, 张珊珊, 季一飞.原发性脑胶质瘤患者术后复发危险因素及预测模型构建[J]. 国际肿瘤学杂志, 2024, 51(4): 193-197.
[2]	肖楠, 孙鹏飞.氧化应激在胶质瘤放化疗敏感性中的研究进展[J]. 国际肿瘤学杂志, 2022, 49(6): 357-361.
[3]	孔春禹, 孙鹏飞.SLC7A11与胶质瘤[J]. 国际肿瘤学杂志, 2022, 49(10): 604-607.
[4]	郭世豪, 任叶青, 郭庚.脑胶质瘤血管生成拟态分子机制[J]. 国际肿瘤学杂志, 2021, 48(6): 362-365.
[5]	王宪伟, 史美燕, 王凤芹, 齐福, 王朝喆, 周飞.TSA上调miR-4298靶向抑制PADI4表达在诱导U251细胞凋亡中的作用[J]. 国际肿瘤学杂志, 2021, 48(4): 193-199.
[6]	张雯, 胡伟国, 宋启斌.3D-ASL与DCE-MRI在脑胶质瘤复发与放射性脑坏死鉴别诊断中的价值[J]. 国际肿瘤学杂志, 2021, 48(10): 631-634.
[7]	赵聪选, 于韬.胶质瘤相关基因的挖掘及预测[J]. 国际肿瘤学杂志, 2020, 47(5): 293-296.
[8]	南阳, 钟跃.长非编码RNA在神经胶质瘤研究中的新进展[J]. 国际肿瘤学杂志, 2020, 47(2): 98-102.
[9]	张雯, 宋启斌, 胡伟国.多模态磁共振成像在脑胶质瘤中的临床应用[J]. 国际肿瘤学杂志, 2020, 47(11): 686-690.
[10]	陈亮, 秦军, 雷军荣, 刘俊, 王璐.miR-1254通过靶向CSF-1抑制胶质瘤细胞的增殖和侵袭能力[J]. 国际肿瘤学杂志, 2020, 47(10): 577-584.
[11]	张千慧, 张洋, 宿伟鹏, 张宋安, 刘攀, 赵化荣.LSD1、MGMT和Ki-67在高级别胶质瘤中的表达及对预后的影响[J]. 国际肿瘤学杂志, 2019, 46(9): 519-525.
[12]	衣琳, 邱实.紫草素抗胶质瘤效应及其作用机制[J]. 国际肿瘤学杂志, 2019, 46(8): 489-491.
[13]	于学娟, 安宏伟, 孙亚梅, 姜政, 张学海, 杨文敬, 张伟. MMP2、TIMP2、Ki-67、P53在胶质瘤组织中的表达及意义[J]. 国际肿瘤学杂志, 2019, 46(12): 718-722.
[14]	卢迪,张钧栋,郭庚,王小刚.干扰素通路中的关键分子诱导脑胶质瘤细胞凋亡的机制[J]. 国际肿瘤学杂志, 2018, 45(7): 432-435.
[15]	张园园，朱淑霞.微小RNA-495在神经胶质瘤中的作用机制[J]. 国际肿瘤学杂志, 2018, 45(6): 362-364.